It’s remarkable how one great product can lead to another. Such was the case with LATISSE®.
Allergan, a leader and pioneer in eye care, dermatology and medical aesthetics, has introduced the world to a range of products, including LATISSE®, the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker. But its origin wasn’t completely new.
Back in 2001, Allergan developed a medicated eye drop used to treat ocular hypertension. In addition to successfully lowering eye pressure (the only treatable risk factor for glaucoma), many patients using this medication experienced a side effect — they began to grow longer, fuller and darker lashes.
This led Allergan to begin its study of this medication’s active ingredient, bimatoprost ophthalmic solution 0.03%, for the sole purpose of generating lash growth. After conducting a clinical trial on safety and efficacy for 4 months on 278 patients, LATISSE® earned its FDA approval in December 2008. Since then, Allergan has sold approximately 1.5 million bottles of LATISSE® solution.
LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
LATISSE® Important Safety Information
If you are using, or have used, prescription products for any eye pressure problems, only use LATISSE® under close doctor care. Although not seen in LATISSE® clinical studies, may cause increased brown pigmentation of the colored part of the eye which is likely permanent. Eyelid skin darkening may occur which may be reversible. Only apply at the base of the upper eyelashes. DO NOT APPLY to the lower eyelid. Hair growth may occur in other skin areas that LATISSE® solution frequently touches. If you develop or experience any eye problems or have eye surgery, consult your doctor immediately about continued use of LATISSE®. The most common side effects after using LATISSE® solution are itchy eyes and/or eye redness. If discontinued, lashes will gradually return to their previous appearance.